Specific inhibition of Ca-activated K channels in red cells by selected dihydropyridine derivatives
- PMID: 8019767
- PMCID: PMC1910101
- DOI: 10.1111/j.1476-5381.1994.tb14823.x
Specific inhibition of Ca-activated K channels in red cells by selected dihydropyridine derivatives
Abstract
1. Thirty two dihydropyridine derivatives were screened as potential inhibitors of the Ca-activated K-channel in human red cells. 2. Three derivatives (26, 29, 32 see Tables 1 and 2) with high activity were then characterized in detail, and also tested against the smooth muscle Ca-channel and shown to have varying potencies. 3. One of the more potent derivatives (32) and nitrendipine were also tested on the Ca-activated K-channel, Maxi-K channel, from mouse pancreatic beta-cells. 4. We conclude from our results that it may be possible to develop selective Gardos-channel inhibitors based on these molecules, which may be of benefit in the treatment of sickle cell disease.
Similar articles
-
Nitrendipine is a potent inhibitor of the Ca(2+)-activated K+ channel of human erythrocytes.FEBS Lett. 1992 Jan 20;296(2):219-21. doi: 10.1016/0014-5793(92)80383-r. FEBS Lett. 1992. PMID: 1733781
-
Pharmacological modulation of calcium and potassium channels in isolated vascular smooth muscle cells.Arzneimittelforschung. 1989 Jan;39(1A):120-6. Arzneimittelforschung. 1989. PMID: 2541731
-
Mode of action and comparative efficacy of pharmacological agents that inhibit calcium-dependent dehydration of sickle cells.Br J Pharmacol. 1992 Aug;106(4):972-7. doi: 10.1111/j.1476-5381.1992.tb14444.x. Br J Pharmacol. 1992. PMID: 1393295 Free PMC article.
-
The Gárdos channel: a review of the Ca2+-activated K+ channel in human erythrocytes.Int J Biochem Cell Biol. 2003 Aug;35(8):1182-97. doi: 10.1016/s1357-2725(02)00310-2. Int J Biochem Cell Biol. 2003. PMID: 12757756 Review.
-
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole.Ann N Y Acad Sci. 1995 Jul 12;763:262-71. doi: 10.1111/j.1749-6632.1995.tb32411.x. Ann N Y Acad Sci. 1995. PMID: 7677336 Review. No abstract available.
Cited by
-
Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis.Front Immunol. 2022 Oct 5;13:997621. doi: 10.3389/fimmu.2022.997621. eCollection 2022. Front Immunol. 2022. PMID: 36275686 Free PMC article. Review.
-
Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:219-240. doi: 10.1146/annurev-pharmtox-010919-023420. Epub 2019 Jul 23. Annu Rev Pharmacol Toxicol. 2020. PMID: 31337271 Free PMC article. Review.
-
Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel KCa3.1.Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2425494122. doi: 10.1073/pnas.2425494122. Epub 2025 Apr 28. Proc Natl Acad Sci U S A. 2025. PMID: 40294255
-
Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma.J Signal Transduct. 2012;2012:421564. doi: 10.1155/2012/421564. Epub 2012 May 17. J Signal Transduct. 2012. PMID: 22675627 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases